Rubisco Pharmaceuticals Private Limited
About Rubisco Pharmaceuticals Private Limited
Data last updated:
Rubisco Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2015PTC024667. Its GSTIN is 10AAHCR4349B1ZV (Bihar).
The company has an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹3.25 Cr. It is led by directors including Sangita Devi and Pinki Ray.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Narendra Kumar Nigam Near Middle School Power House Karbigahiya, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.54 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹7.07 Lakh (net margin 1.6%) and EBITDA of ₹22.06 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rubisco Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Narendra Kumar Nigam Near Middle School Power House Karbigahiya, Patna, Bihar, India – 800001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rubisco Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rubisco Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rubisco Pharmaceuticals Private Limited, buy the company report.
Financials of Rubisco Pharmaceuticals Private Limited
FY 2025 filings availableRubisco Pharmaceuticals Private Limited reported revenue of ₹4.54 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 13% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rubisco Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rubisco Pharmaceuticals Private Limited
Rubisco Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangita Devi | Director | 01 Mar 2024 | 2 Years 7 Months | Current |
| Pinki Ray | Director | 29 Jul 2015 | 11 Years 2 Months | Current |
| Soniya Nigam Also directs: Bastien Chemicals Private Limited | Director | 29 Jul 2015 | 11 Years 2 Months | Current |
Peer comparison
Rubisco Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Joslin Pharmaa India Private Limited | ₹4.55 Cr (FY 2024) | 12.0% | Coimbatore, Tamil Nadu, India | |||
| Chemiquest Research India Private Limited | ₹4.55 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Rubisco Pharmaceuticals Private Limitedthis company | ₹4.54 Cr (FY 2025) | ₹7.07 Lakh | 1.6% | 13.0% | 13 | Patna, Bihar, India |
| Surbhitam Pharmaceuticals Private Limited | ₹4.54 Cr (FY 2025) | 23.0% | New Delhi, Delhi, India | |||
| Lee Health Domain India Private Limited | ₹4.53 Cr (FY 2025) | 118.0% | Hyderabad, Telangana, India | |||
| Novelix Pharmaceuticals Limited | ₹4.53 Cr (FY 2024) | 136.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Rubisco Pharmaceuticals Private Limited, buy the company report.
Auditor
Rubisco Pharmaceuticals Private Limited is audited by Jainendra Kumar & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jainendra Kumar & Associates | FY 2023 | 528031 |
Shareholding
The shareholding of Rubisco Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rubisco Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2017 | 100133829 | State Bank of India | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Rubisco Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Rubisco Pharmaceuticals, 1 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (REQ. CASE) | Filed by the company against Nutrimed Health Care Pvt. Ltd. and 1 other | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by L and T Finance Limited. | Pending |
To see the full case history of Rubisco Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rubisco Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rubisco Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
Rubisco Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCR4349B1ZV | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rubisco Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rubisco Pharmaceuticals Private Limited has 5 board changes on record since 2015: 3 appointments and 2 cessations. The latest: Abhinita ceased to be Director on 31 Mar 2024.
Frequently asked questions
Rubisco Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 July 2015 (11+ years old) and is registered under CIN U24230BR2015PTC024667.
Rubisco Pharmaceuticals has 3 current directors:
- Sangita Devi - Director
- Pinki Ray - Director
- Soniya Nigam - Director
The latest financial statements of Rubisco Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Rubisco Pharmaceuticals is 10AAHCR4349B1ZV, registered in Bihar.
The CIN (Corporate Identification Number) of Rubisco Pharmaceuticals is U24230BR2015PTC024667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rubisco Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Rubisco Pharmaceuticals was incorporated on 29 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Rubisco Pharmaceuticals by revenue are Joslin Pharmaa India Private Limited, Chemiquest Research India Private Limited, Surbhitam Pharmaceuticals Private Limited, Lee Health Domain India Private Limited, Novelix Pharmaceuticals Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhinita ceased to be Director on 31 Mar 2024. Sangita Devi was appointed as Director on 01 Mar 2024. Ajay Kumar Jha ceased to be Director on 01 Mar 2021. Rubisco Pharmaceuticals has 5 board changes on record in total.
The registered office of Rubisco Pharmaceuticals is at CO Narendra Kumar Nigam Near Middle School Power House Karbigahiya, Patna, Bihar, India – 800001.
Rubisco Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.